Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_assertion type Assertion NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_head.
- NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_assertion description "[A sustained virological response secondary to IFN monotherapy or IFN/RBV combination therapy could reduce the risk for HCC and improve survival of CHC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_provenance.
- NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_assertion evidence source_evidence_literature NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_provenance.
- NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_assertion SIO_000772 17302368 NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_provenance.
- NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_assertion wasDerivedFrom befree-20140225 NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_provenance.
- NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_assertion wasGeneratedBy ECO_0000203 NP212949.RADKDGZ7icB8FvA6ioTFq3_7vg-8Ir2ZBsnbsH71FWQeQ130_provenance.